Brandon Couillard
Stock Analyst at Wells Fargo
(4.67)
# 169
Out of 5,090 analysts
161
Total ratings
66.33%
Success rate
18.97%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Equal-Weight | $110 | $111.64 | -1.47% | 1 | Dec 1, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $150 → $175 | $145.49 | +20.28% | 25 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $90 → $105 | $101.06 | +3.90% | 19 | Nov 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,200 → $1,400 | $1,414.86 | -1.05% | 6 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $175 → $190 | $244.55 | -22.31% | 2 | Nov 7, 2025 | |
| TECH Bio-Techne | Maintains: Overweight | $59 → $70 | $61.68 | +13.49% | 2 | Nov 6, 2025 | |
| WAT Waters | Maintains: Equal-Weight | $315 → $385 | $394.81 | -2.48% | 6 | Nov 5, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $48 | $48.03 | -0.06% | 6 | Nov 5, 2025 | |
| MYGN Myriad Genetics | Maintains: Equal-Weight | $6 → $6.5 | $7.09 | -8.32% | 3 | Nov 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $95 → $140 | $158.96 | -11.93% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $317.69 | +7.02% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $317.05 | +7.24% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 → $635 | $572.77 | +10.86% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $205 → $230 | $226.25 | +1.66% | 4 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $72 | $102.02 | -29.43% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $19 → $14 | $18.53 | -24.45% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $100 → $67 | $77.63 | -13.69% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $10.93 | +46.39% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 → $175 | $164.98 | +6.07% | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $130 → $102 | $100.79 | +1.20% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $157.21 | +65.38% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $73.62 | +8.67% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $3.70 | +170.27% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $20.23 | +13.69% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.03 | +540.39% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.49 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.83 | +501.09% | 2 | Oct 13, 2017 |
BillionToOne
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $111.64
Upside: -1.47%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $145.49
Upside: +20.28%
Exact Sciences
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $101.06
Upside: +3.90%
Mettler-Toledo International
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $1,200 → $1,400
Current: $1,414.86
Upside: -1.05%
Natera
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $175 → $190
Current: $244.55
Upside: -22.31%
Bio-Techne
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $61.68
Upside: +13.49%
Waters
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $315 → $385
Current: $394.81
Upside: -2.48%
Bruker
Nov 5, 2025
Maintains: Overweight
Price Target: $50 → $48
Current: $48.03
Upside: -0.06%
Myriad Genetics
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $7.09
Upside: -8.32%
GeneDx Holdings
Nov 4, 2025
Maintains: Equal-Weight
Price Target: $95 → $140
Current: $158.96
Upside: -11.93%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $317.69
Upside: +7.02%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $317.05
Upside: +7.24%
Oct 23, 2025
Maintains: Overweight
Price Target: $565 → $635
Current: $572.77
Upside: +10.86%
Oct 23, 2025
Maintains: Equal-Weight
Price Target: $205 → $230
Current: $226.25
Upside: +1.66%
Sep 22, 2025
Initiates: Overweight
Price Target: $72
Current: $102.02
Upside: -29.43%
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $19 → $14
Current: $18.53
Upside: -24.45%
Aug 8, 2025
Upgrades: Equal-Weight
Price Target: $100 → $67
Current: $77.63
Upside: -13.69%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $10.93
Upside: +46.39%
Jul 30, 2025
Maintains: Overweight
Price Target: $180 → $175
Current: $164.98
Upside: +6.07%
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $100.79
Upside: +1.20%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $157.21
Upside: +65.38%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $73.62
Upside: +8.67%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $3.70
Upside: +170.27%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $20.23
Upside: +13.69%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $2.03
Upside: +540.39%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.49
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.83
Upside: +501.09%